US Stock MarketDetailed Quotes

IPSC Century Therapeutics

Watchlist
  • 0.513
  • -0.036-6.47%
Close Mar 28 16:00 ET
  • 0.516
  • +0.003+0.60%
Post 20:01 ET
44.13MMarket Cap-0.32P/E (TTM)

Century Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
194.81%6.59M
1,457.09%4.17M
434.46%791K
678.79%771K
-50.29%855K
-57.01%2.24M
-48.56%268K
-93.35%148K
-92.91%99K
62.57%1.72M
Operating revenue
194.81%6.59M
1,457.09%4.17M
434.46%791K
678.79%771K
-50.29%855K
-57.01%2.24M
-48.56%268K
-93.35%148K
-92.91%99K
62.57%1.72M
Cost of revenue
Gross profit
Operating expense
10.19%140.4M
20.22%37.13M
11.98%35.58M
14.76%35.53M
-4.84%32.16M
-1.25%127.42M
-8.70%30.89M
-6.44%31.77M
-5.47%30.96M
18.62%33.8M
Selling and administrative expenses
-4.47%33.16M
-9.71%7.76M
-7.06%8.35M
0.94%8.31M
-1.79%8.74M
8.94%34.71M
4.21%8.59M
11.43%8.99M
-0.29%8.23M
21.98%8.9M
-General and administrative expense
-4.47%33.16M
-9.71%7.76M
-7.06%8.35M
0.94%8.31M
-1.79%8.74M
8.94%34.71M
4.21%8.59M
11.43%8.99M
-0.29%8.23M
21.98%8.9M
Research and development costs
15.68%107.24M
31.75%29.38M
19.48%27.23M
19.77%27.22M
-5.94%23.42M
-4.59%92.71M
-12.86%22.3M
-12.01%22.79M
-7.21%22.73M
17.47%24.9M
Operating profit
-6.89%-133.81M
-7.64%-32.96M
-10.00%-34.79M
-12.63%-34.76M
2.41%-31.31M
-1.09%-125.18M
8.07%-30.62M
0.35%-31.63M
1.58%-30.86M
-16.93%-32.08M
Net non-operating interest income expense
7.17%13.01M
-17.92%2.88M
-5.19%3.31M
22.59%3.58M
45.88%3.24M
305.92%12.14M
114.42%3.51M
235.84%3.49M
677.13%2.92M
3,737.70%2.22M
Non-operating interest income
2.60%13.01M
-17.92%2.88M
-5.19%3.31M
17.14%3.58M
23.41%3.24M
186.81%12.68M
71.22%3.51M
147.06%3.49M
333.14%3.06M
936.76%2.62M
Non-operating interest expense
--0
--0
--0
--0
--0
-55.00%540K
--0
--0
-46.46%136K
46.22%348K
Total other finance cost
----
----
----
----
----
----
----
----
----
-26.32%56K
Other net income (expense)
81.73%-3.97M
67.93%-4.22M
106.27%250K
99.73%-12K
105.67%11K
-117.48%-21.75M
-69,363.16%-13.16M
-16,516.67%-3.99M
-88,220.00%-4.41M
98.06%-194K
Special income (charges)
79.75%-4.33M
67.08%-4.33M
--0
--0
----
-113.65%-21.37M
---13.15M
---4M
---4.22M
----
-Less:Impairment of capital assets
-73.56%4.33M
-64.37%4.33M
--0
--0
----
--16.37M
--12.15M
--0
--4.22M
----
-Less:Other special charges
----
----
----
----
----
-50.00%5M
--1M
--4M
----
----
Other non- operating income (expenses)
192.43%354K
806.67%106K
1,983.33%250K
93.55%-12K
105.67%11K
---383K
---15K
150.00%12K
-3,820.00%-186K
---194K
Income before tax
7.43%-124.78M
14.83%-34.3M
2.78%-31.23M
3.57%-31.19M
6.64%-28.06M
-3.02%-134.79M
-27.23%-40.27M
-4.57%-32.13M
-4.43%-32.34M
19.84%-30.06M
Income tax
-4.84%1.79M
304.37%1.78M
-101.35%-8K
-97.68%22K
-99.92%1K
1,967.03%1.88M
-2,815.63%-869K
2,268.00%592K
5,177.78%950K
7,450.00%1.21M
Net income
7.40%-126.57M
8.44%-36.07M
4.57%-31.23M
6.26%-31.21M
10.24%-28.06M
-4.38%-136.67M
-24.35%-39.4M
-6.41%-32.72M
-7.43%-33.29M
16.66%-31.26M
Net income continuous Operations
7.40%-126.57M
8.44%-36.07M
4.57%-31.23M
6.26%-31.21M
10.24%-28.06M
-4.38%-136.67M
-24.35%-39.4M
-6.41%-32.72M
-7.43%-33.29M
16.66%-31.26M
Minority interest income
Net income attributable to the parent company
7.40%-126.57M
8.44%-36.07M
4.57%-31.23M
6.26%-31.21M
10.24%-28.06M
-4.38%-136.67M
-24.35%-39.4M
-6.41%-32.72M
-7.43%-33.29M
16.66%-31.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
7.40%-126.57M
8.44%-36.07M
4.57%-31.23M
6.26%-31.21M
10.24%-28.06M
-4.38%-136.67M
-24.35%-39.4M
-6.41%-32.72M
-7.43%-33.29M
16.66%-31.26M
Basic earnings per share
30.00%-1.61
33.85%-0.43
32.73%-0.37
32.14%-0.38
15.09%-0.45
-1.32%-2.3
-18.18%-0.65
-3.77%-0.55
-3.70%-0.56
19.70%-0.53
Diluted earnings per share
30.00%-1.61
33.85%-0.43
32.73%-0.37
32.14%-0.38
15.09%-0.45
-1.32%-2.3
-18.18%-0.65
-3.77%-0.55
-3.70%-0.56
19.70%-0.53
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 194.81%6.59M1,457.09%4.17M434.46%791K678.79%771K-50.29%855K-57.01%2.24M-48.56%268K-93.35%148K-92.91%99K62.57%1.72M
Operating revenue 194.81%6.59M1,457.09%4.17M434.46%791K678.79%771K-50.29%855K-57.01%2.24M-48.56%268K-93.35%148K-92.91%99K62.57%1.72M
Cost of revenue
Gross profit
Operating expense 10.19%140.4M20.22%37.13M11.98%35.58M14.76%35.53M-4.84%32.16M-1.25%127.42M-8.70%30.89M-6.44%31.77M-5.47%30.96M18.62%33.8M
Selling and administrative expenses -4.47%33.16M-9.71%7.76M-7.06%8.35M0.94%8.31M-1.79%8.74M8.94%34.71M4.21%8.59M11.43%8.99M-0.29%8.23M21.98%8.9M
-General and administrative expense -4.47%33.16M-9.71%7.76M-7.06%8.35M0.94%8.31M-1.79%8.74M8.94%34.71M4.21%8.59M11.43%8.99M-0.29%8.23M21.98%8.9M
Research and development costs 15.68%107.24M31.75%29.38M19.48%27.23M19.77%27.22M-5.94%23.42M-4.59%92.71M-12.86%22.3M-12.01%22.79M-7.21%22.73M17.47%24.9M
Operating profit -6.89%-133.81M-7.64%-32.96M-10.00%-34.79M-12.63%-34.76M2.41%-31.31M-1.09%-125.18M8.07%-30.62M0.35%-31.63M1.58%-30.86M-16.93%-32.08M
Net non-operating interest income expense 7.17%13.01M-17.92%2.88M-5.19%3.31M22.59%3.58M45.88%3.24M305.92%12.14M114.42%3.51M235.84%3.49M677.13%2.92M3,737.70%2.22M
Non-operating interest income 2.60%13.01M-17.92%2.88M-5.19%3.31M17.14%3.58M23.41%3.24M186.81%12.68M71.22%3.51M147.06%3.49M333.14%3.06M936.76%2.62M
Non-operating interest expense --0--0--0--0--0-55.00%540K--0--0-46.46%136K46.22%348K
Total other finance cost -------------------------------------26.32%56K
Other net income (expense) 81.73%-3.97M67.93%-4.22M106.27%250K99.73%-12K105.67%11K-117.48%-21.75M-69,363.16%-13.16M-16,516.67%-3.99M-88,220.00%-4.41M98.06%-194K
Special income (charges) 79.75%-4.33M67.08%-4.33M--0--0-----113.65%-21.37M---13.15M---4M---4.22M----
-Less:Impairment of capital assets -73.56%4.33M-64.37%4.33M--0--0------16.37M--12.15M--0--4.22M----
-Less:Other special charges ---------------------50.00%5M--1M--4M--------
Other non- operating income (expenses) 192.43%354K806.67%106K1,983.33%250K93.55%-12K105.67%11K---383K---15K150.00%12K-3,820.00%-186K---194K
Income before tax 7.43%-124.78M14.83%-34.3M2.78%-31.23M3.57%-31.19M6.64%-28.06M-3.02%-134.79M-27.23%-40.27M-4.57%-32.13M-4.43%-32.34M19.84%-30.06M
Income tax -4.84%1.79M304.37%1.78M-101.35%-8K-97.68%22K-99.92%1K1,967.03%1.88M-2,815.63%-869K2,268.00%592K5,177.78%950K7,450.00%1.21M
Net income 7.40%-126.57M8.44%-36.07M4.57%-31.23M6.26%-31.21M10.24%-28.06M-4.38%-136.67M-24.35%-39.4M-6.41%-32.72M-7.43%-33.29M16.66%-31.26M
Net income continuous Operations 7.40%-126.57M8.44%-36.07M4.57%-31.23M6.26%-31.21M10.24%-28.06M-4.38%-136.67M-24.35%-39.4M-6.41%-32.72M-7.43%-33.29M16.66%-31.26M
Minority interest income
Net income attributable to the parent company 7.40%-126.57M8.44%-36.07M4.57%-31.23M6.26%-31.21M10.24%-28.06M-4.38%-136.67M-24.35%-39.4M-6.41%-32.72M-7.43%-33.29M16.66%-31.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 7.40%-126.57M8.44%-36.07M4.57%-31.23M6.26%-31.21M10.24%-28.06M-4.38%-136.67M-24.35%-39.4M-6.41%-32.72M-7.43%-33.29M16.66%-31.26M
Basic earnings per share 30.00%-1.6133.85%-0.4332.73%-0.3732.14%-0.3815.09%-0.45-1.32%-2.3-18.18%-0.65-3.77%-0.55-3.70%-0.5619.70%-0.53
Diluted earnings per share 30.00%-1.6133.85%-0.4332.73%-0.3732.14%-0.3815.09%-0.45-1.32%-2.3-18.18%-0.65-3.77%-0.55-3.70%-0.5619.70%-0.53
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More